Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $7.84 is 91.22% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 8.36||$ 14|
|Low:||$ 7.65||$ 4.10|
Company Description (as filed with the SEC)
As used in this Form 10-K, "we," "us," and "our" refer to Insys Therapeutics, Inc. and our subsidiaries. We are a commercial-stage specialty pharmaceutical company that develops and commercializes innovative supportive care products. We have two marketed products: SUBSYS®, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and SYNDROS®, a proprietary, orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. Insys Therapeutics, Inc. was incorporated in Delaware in June 1990, and maintains headquarters in Chandler, Arizona. For further detail concerning our company and communities, see the "Available Information" section included in this Item 1. ... More ...
Nasdaq Official Price
Jul. 20, 2018
Jul. 20, 2018